Company intelligence
MFX
The Cyto Engine - industrializing cell and gene therapy manufacturing
Automation Machinery Manufacturing
Stevenage, GB
43 employees
Founded 2020
2 public signals
About MFX
MFX presents the Cyto Engine, a unified bioreactor and data platform for cell and gene therapy research, development, and manufacturing
Verified activity
Signals from MFX
2 published signals
Research & Knowledge
MFX through phenotypic assessment found that the supplement enabled a 30% increase in proliferation via Ki-67, a 90% reduction in replicative senescence, and a 20–25% reduction in exhaustion markers
Reported by MFX
Research & Knowledge
MFX collaborated with Tolemy Bio to combine the adaptability of the Cyto Engine with Tolemy’s AI-powered media optimisation to increase total T-cell growth by 15%
Reported by MFX